old PR's for the Reborn and Qixleef trials. https
Post# of 87
https://ir.tetrabiopharma.com/newsroom/press-...fault.aspx
https://ir.tetrabiopharma.com/newsroom/press-...fault.aspx
https://www.prnewswire.com/news-releases/tetr...31210.html
https://www.biospace.com/article/releases/tet...cal-trial/